Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Renal denervation improves cardiac function independently of afterload and restores myocardial norepinephrine levels in a rodent heart failure model

M. Miklovič, O. Gawryś, Z. Honetschlägerová, P. Kala, Z. Husková, S. Kikerlová, Z. Vaňourková, Š. Jíchová, A. Kvasilová, M. Kitamoto, H. Maxová, G. Puertas-Frias, T. Mráček, D. Sedmera, V. Melenovský

. 2024 ; 47 (10) : 2718-2730. [pub] 20240202

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25004090
E-zdroje Online Plný text

NLK ProQuest Central od 2015-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2015-01-01 do Před 1 rokem

Renal nerves play a critical role in cardiorenal interactions. Renal denervation (RDN) improved survival in some experimental heart failure (HF) models. It is not known whether these favorable effects are indirect, explainable by a decrease in vascular afterload, or diminished neurohumoral response in the kidneys, or whether RDN procedure per se has direct myocardial effects in the failing heart. To elucidate mechanisms how RDN affects failing heart, we studied load-independent indexes of ventricular function, gene markers of myocardial remodeling, and cardiac sympathetic signaling in HF, induced by chronic volume overload (aorto-caval fistula, ACF) of Ren2 transgenic rats. Volume overload by ACF led to left ventricular (LV) hypertrophy and dysfunction, myocardial remodeling (upregulated Nppa, MYH 7/6 genes), increased renal and circulating norepinephrine (NE), reduced myocardial NE content, increased monoaminoxidase A (MAO-A), ROS production and decreased tyrosine hydroxylase (+) nerve staining. RDN in HF animals decreased congestion in the lungs and the liver, improved load-independent cardiac function (Ees, PRSW, Ees/Ea ratio), without affecting arterial elastance or LV pressure, reduced adverse myocardial remodeling (Myh 7/6, collagen I/III ratio), decreased myocardial MAO-A and inhibited renal neprilysin activity. RDN increased myocardial expression of acetylcholinesterase (Ache) and muscarinic receptors (Chrm2), decreased circulating and renal NE, but increased myocardial NE content, restoring so autonomic control of the heart. These changes likely explain improvements in survival after RDN in this model. The results suggest that RDN has remote, load-independent and favorable intrinsic myocardial effects in the failing heart. RDN therefore could be a useful therapeutic strategy in HF.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25004090
003      
CZ-PrNML
005      
20250206105126.0
007      
ta
008      
250121s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41440-024-01580-3 $2 doi
035    __
$a (PubMed)38302774
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Miklovič, Matúš $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic $u Department of Pathophysiology, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic
245    10
$a Renal denervation improves cardiac function independently of afterload and restores myocardial norepinephrine levels in a rodent heart failure model / $c M. Miklovič, O. Gawryś, Z. Honetschlägerová, P. Kala, Z. Husková, S. Kikerlová, Z. Vaňourková, Š. Jíchová, A. Kvasilová, M. Kitamoto, H. Maxová, G. Puertas-Frias, T. Mráček, D. Sedmera, V. Melenovský
520    9_
$a Renal nerves play a critical role in cardiorenal interactions. Renal denervation (RDN) improved survival in some experimental heart failure (HF) models. It is not known whether these favorable effects are indirect, explainable by a decrease in vascular afterload, or diminished neurohumoral response in the kidneys, or whether RDN procedure per se has direct myocardial effects in the failing heart. To elucidate mechanisms how RDN affects failing heart, we studied load-independent indexes of ventricular function, gene markers of myocardial remodeling, and cardiac sympathetic signaling in HF, induced by chronic volume overload (aorto-caval fistula, ACF) of Ren2 transgenic rats. Volume overload by ACF led to left ventricular (LV) hypertrophy and dysfunction, myocardial remodeling (upregulated Nppa, MYH 7/6 genes), increased renal and circulating norepinephrine (NE), reduced myocardial NE content, increased monoaminoxidase A (MAO-A), ROS production and decreased tyrosine hydroxylase (+) nerve staining. RDN in HF animals decreased congestion in the lungs and the liver, improved load-independent cardiac function (Ees, PRSW, Ees/Ea ratio), without affecting arterial elastance or LV pressure, reduced adverse myocardial remodeling (Myh 7/6, collagen I/III ratio), decreased myocardial MAO-A and inhibited renal neprilysin activity. RDN increased myocardial expression of acetylcholinesterase (Ache) and muscarinic receptors (Chrm2), decreased circulating and renal NE, but increased myocardial NE content, restoring so autonomic control of the heart. These changes likely explain improvements in survival after RDN in this model. The results suggest that RDN has remote, load-independent and favorable intrinsic myocardial effects in the failing heart. RDN therefore could be a useful therapeutic strategy in HF.
650    _2
$a zvířata $7 D000818
650    12
$a srdeční selhání $x patofyziologie $x metabolismus $7 D006333
650    12
$a noradrenalin $x krev $x metabolismus $7 D009638
650    12
$a ledviny $x inervace $x metabolismus $7 D007668
650    _2
$a krysa rodu Rattus $7 D051381
650    12
$a myokard $x metabolismus $7 D009206
650    12
$a modely nemocí na zvířatech $7 D004195
650    _2
$a mužské pohlaví $7 D008297
650    12
$a potkani transgenní $7 D055647
650    _2
$a remodelace komor $x fyziologie $7 D020257
650    _2
$a sympatektomie $7 D013562
650    _2
$a srdce $x inervace $x patofyziologie $7 D006321
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gawryś, Olga $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic
700    1_
$a Honetschlägerová, Zuzana $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic
700    1_
$a Kala, Petr $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic $u Department of Cardiology, University Hospital Motol and 2nd Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Husková, Zuzana $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic
700    1_
$a Kikerlová, Soňa $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic
700    1_
$a Vaňourková, Zdeňka $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic
700    1_
$a Jíchová, Šárka $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic
700    1_
$a Kvasilová, Alena $u Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Kitamoto, Misuzu $u Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Maxová, Hana $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic $u Department of Pathophysiology, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Puertas-Frias, Guillermo $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Mráček, Tomáš $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Sedmera, David $u Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Melenovský, Vojtěch $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic. vojtech.melenovsky@ikem.cz $u Department of Cardiology, Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic. vojtech.melenovsky@ikem.cz
773    0_
$w MED00006041 $t Hypertension research $x 1348-4214 $g Roč. 47, č. 10 (2024), s. 2718-2730
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38302774 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206105122 $b ABA008
999    __
$a ok $b bmc $g 2263692 $s 1240097
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 47 $c 10 $d 2718-2730 $e 20240202 $i 1348-4214 $m Hypertension research $n Hypertens Res $x MED00006041
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...